Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.93
-$0.01-0.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.29% | 85.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.92% | 2.24% | |||
| Operating Income | -9.92% | -2.24% | |||
| Income Before Tax | -10.30% | -6.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.30% | -6.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.30% | -6.39% | |||
| EBIT | -9.92% | -2.24% | |||
| EBITDA | -10.01% | -2.13% | |||
| EPS Basic | -8.97% | -4.99% | |||
| Normalized Basic EPS | -8.96% | -4.99% | |||
| EPS Diluted | -8.97% | -4.84% | |||
| Normalized Diluted EPS | -8.96% | -4.99% | |||
| Average Basic Shares Outstanding | 1.22% | 1.34% | |||
| Average Diluted Shares Outstanding | 1.22% | 1.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||